Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fulminant demyelinating diseases.
T-cell vaccination in multiple sclerosis: update on clinical application and mode of action.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
Value of NMO-IgG determination at the time of presentation as CIS.
Cognitive dysfunction in early multiple sclerosis: altered centrality derived from resting-state functional connectivity using magneto-encephalography.
Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering.
[Optic neuropathy and meningioma: A diagnostic trap.]
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Evidence for a two-stage disability progression in multiple sclerosis.
Aspirin and multiple sclerosis.
Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy.
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Cognitive Impairment in Multiple Sclerosis.
Information regarding Active Biotech's candidate drug laquinimod
Epidemiology in multiple sclerosis: a pilgrim's progress.
Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model.
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis.
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
Pitfalls of 3D FLAIR Brain Imaging: A Prospective Comparison with 2D FLAIR.
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?

Pages